Astell units sterilise contaminated lab waste

Published: 9-Jun-2010
Manufacturing Sustainability Regulatory

Astell markets liquid waste treatment plants for Category 3 and 4 labs

Autoclave and steriliser manufacturer, Astell, has introduced a range of contaminated liquid waste containment and treatment plants for Category 3 and 4 laboratories, including veterinary and medical research, pharmaceutical manufacturing and healthcare.

Current legislation requires that all waste water from sinks, washrooms, sanitary installations and similar facilities within these designated areas have to be sterilised prior to discharge to sewer. The Astell units cover capacities from 100 to 5000 litres of liquid waste per day.

In the standard batch processing unit, liquid waste is collected in a stainless steel jacketed containment tank. When the radar level controller detects that the tank is full, the heat sterilisation sequence starts automatically.

Heating is by steam supplied either from the unit’s integral steam generator or from an external source. Once the sequence is complete, the sterilised effluent is discharged to sewer using compressed air.

Continuous processing units are provided with two tanks. The first tank is filled as in the batch operation, and commences sterilisation. Influent liquid waste is then diverted to the second tank. When the sterilisation sequence is complete, the tank remains idle until the second tank is full. In this way effluent collection is continuous so there is no delay to laboratory operations.

Each tank is fully contained and all connections are above liquid level eliminating dangerous and costly leaks. A vent filter ensures that no microbial contaminants can be discharged with air or vapour. Access to the fully programmable controller is via Astell’s PIN protected, full colour touch screen which displays cycle information and has facilities for data archiving and ethernet monitoring.

Astell offers full project assistance including an initial site survey to ascertain the volume of waste and advise the best treatment method, detailed engineering proposals, manufacture, delivery and installation of the equipment and IQ and OQ validation packages.

See more

You may also like

Containment

Biocontainment facilities: Down the drain

Read more
Graham Scarr, Technical Director of AstellBio, discusses approaches to effluent decontamination in containment level 2 and level 3 facilities

Trending Articles

  1. Roche wins CE mark for first blood-based immunoassay to identify ApoE4 Alzheimer's risk variant Roche's Elecsys ApoE4 test has received CE mark approval as the first in-vitro diagnostic immunoassay to detect the ApoE4 genetic variant from a simple blood sample, potentially eliminating the need for confirmatory DNA testing in Alzheimer's patients who do not carry the variant
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Moving with speed and scale: innovative, material-sparing approaches to accelerate clinical development As early-stage drug development is often hindered by limited API supply, rising costs and tight timelines, material-sparing technologies are helping companies to progress faster with less
  3. Why weight sorting should move earlier in OSD development Phillip Ruda explains how earlier weight intelligence can improve process understanding, reduce risk and accelerate learning cycles
  4. Orphan drug sales to exceed $400bn by 2032, Evaluate report finds Despite FDA policy shifts and the rise of blockbuster obesity drugs, a new Evaluate report confirms rare disease therapies are on track to claim more than a fifth of all global prescription drug sales within a decade
  5. Lyocontract invests €50m in new freeze-drying facility with Syntegon vial line German CDMO Lyocontract has begun construction of a €50m expansion in Ilsenburg, partnering with Syntegon to install a complete vial filling and lyophilisation line for sterile freeze-dried pharmaceuticals

Upcoming event

DCAT Week

23–26 March 2026 | Conference | New York, US See all

You may also like

Containment

Biocontainment facilities: Down the drain

Graham Scarr, Technical Director of AstellBio, discusses approaches to effluent decontamination in containment level 2 and level 3 facilities
Manufacturing

Astell helps the fight against cancer

Astell Scientific, the UK’s leading supplier of autoclaves, is helping to ensure the safety and reliability of laboratory work at Barts Cancer Institute, Queen Mary University of London
Manufacturing

Astell expands steam generator range

Free-standing models designed with peak demand in mind
Regulatory

E for Essential

E range autoclaves from Astell offer a small price tag and a small footprint
Manufacturing

Clariant opens first US pharmaceutical-grade PEG excipient manufacturing site in Texas

Clariant has expanded its Clear Lake facility in Texas to produce GMP-compliant pharmaceutical-grade polyethylene glycol excipients, marking its first US-based manufacturing site for the products and strengthening supply chain resilience for North American and Latin American pharma customers
Design & Build

ESTEVE CDMO expands spray drying and high-potency containment capacity at Girona facility

ESTEVE CDMO has announced plans to add a 3000-square-metre production unit at its Celrà site in Spain to house additional spray drying equipment and high-potency containment suites, with the first new GEA spray dryer due online in Q1 2027
Manufacturing

Abzena named a leader in Frost & Sullivan ADC CDMO radar report

Recognition highlights integrated capabilities, proprietary technology and expertise in antibody-drug conjugates
Subscribe now